LV11821A - Savienojumu ar fosfonamida vai enola fosfata saiti pielietojums audzeju arstesanai - Google Patents

Savienojumu ar fosfonamida vai enola fosfata saiti pielietojums audzeju arstesanai

Info

Publication number
LV11821A
LV11821A LV970018A LV970018A LV11821A LV 11821 A LV11821 A LV 11821A LV 970018 A LV970018 A LV 970018A LV 970018 A LV970018 A LV 970018A LV 11821 A LV11821 A LV 11821A
Authority
LV
Latvia
Prior art keywords
treatment
compounds
tumors
phosphonamide
enol phosphate
Prior art date
Application number
LV970018A
Other languages
English (en)
Other versions
LV11821B (en
Inventor
Nicole Bru
Victor Izrael
Original Assignee
Nicole Bru
Victor Izrael
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicole Bru, Victor Izrael filed Critical Nicole Bru
Publication of LV11821A publication Critical patent/LV11821A/lv
Publication of LV11821B publication Critical patent/LV11821B/lv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LVP-97-18A 1991-12-03 1997-02-05 Use of creatine phosphate or phosphoenolpyruvic acid for the treatment of tumours LV11821B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9114967A FR2684381B1 (fr) 1991-12-03 1991-12-03 Composes presentant une liaison amide phosphorique ou une liaison phosphate d'enol pour leur application en tant que substance therapeutiquement active.
PCT/FR1992/001118 WO1993010792A1 (fr) 1991-12-03 1992-12-01 Utilisation de la creatine phosphate ou de l'acide phosphoenol pyruvique pour le traitement des tumeurs

Publications (2)

Publication Number Publication Date
LV11821A true LV11821A (lv) 1997-08-20
LV11821B LV11821B (en) 1997-12-20

Family

ID=9419629

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-97-18A LV11821B (en) 1991-12-03 1997-02-05 Use of creatine phosphate or phosphoenolpyruvic acid for the treatment of tumours

Country Status (21)

Country Link
US (1) US5219846A (lv)
EP (1) EP0614366B1 (lv)
JP (1) JP3437574B2 (lv)
KR (1) KR100235893B1 (lv)
AT (1) ATE142499T1 (lv)
AU (1) AU3260093A (lv)
BG (1) BG61595B1 (lv)
CA (1) CA2124793C (lv)
CZ (1) CZ284966B6 (lv)
DE (1) DE69213757T2 (lv)
DK (1) DK0614366T3 (lv)
ES (1) ES2094522T3 (lv)
FR (1) FR2684381B1 (lv)
GR (1) GR3021876T3 (lv)
HU (1) HU216826B (lv)
LV (1) LV11821B (lv)
RO (1) RO115784B1 (lv)
RU (1) RU2097040C1 (lv)
SK (1) SK280785B6 (lv)
UA (1) UA41285C2 (lv)
WO (1) WO1993010792A1 (lv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994016712A1 (en) * 1993-01-27 1994-08-04 Amira, Inc. Creatine phosphate, creatine phosphate analogs, and uses therefor
AU6165894A (en) * 1993-01-28 1994-08-15 Trustees Of The University Of Pennsylvania, The Use of creatine or analogs for the manufacture of a medicament for inhibiting tumor growth
US5714361A (en) * 1994-02-14 1998-02-03 Indiana University Foundation Phosphatase/phosphodiesterase enzyme inhibitors and methods
US5627172A (en) * 1994-03-04 1997-05-06 Natural Supplement Association, Incorporated Method for reduction of serum blood lipids or lipoprotein fraction
DE19537494C2 (de) * 1995-09-25 1997-10-02 Desitin Arzneimittel Gmbh Kreatin zum Schutz von neuralem Gewebe
DE19653225A1 (de) * 1996-12-20 1998-06-25 Sueddeutsche Kalkstickstoff Kreatin-pyruvate und Verfahren zu deren Herstellung
DE10116589A1 (de) * 2001-04-03 2002-10-10 Wulf Droege Anwendung von Kreatin zur Minderung von oxidativem Stress
US9060993B2 (en) * 2003-05-09 2015-06-23 The Trustees Of The University Of Pennsylvania Compositions and methods for treating cancer
US8350077B2 (en) 2008-12-24 2013-01-08 Vertex Closed Joint Stock Company Amides of creatine, method of their preparation, and remedy possessing a neuroprotective activity
RU2428414C2 (ru) 2009-11-03 2011-09-10 Закрытое Акционерное Общество "Вертекс" Способ получения амидов креатина
WO2016007622A1 (en) * 2014-07-09 2016-01-14 Sidra Medical and Research Center Imaging of creatine kinase enzyme expression in cancerous tissues

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8200252L (sv) * 1982-01-18 1983-07-19 Pharmacia Ab Farmaceutisk komposition
IT1214598B (it) * 1985-04-17 1990-01-18 Schiapparelli Farma Uso terapeutico della fosfocreatina.
IT1191639B (it) * 1985-11-11 1988-03-23 Schiapparelli Farma Composizione farmaceutica contenente fosfocreatina e metodo per preparla
US4874882A (en) * 1986-03-25 1989-10-17 Ube Industries, Ltd. Process for preparing monosodium phosphoenolpyruvate
US4769318A (en) * 1986-06-03 1988-09-06 Ube Industries, Ltd. Additive solution for blood preservation and activation

Also Published As

Publication number Publication date
EP0614366B1 (fr) 1996-09-11
HU9401656D0 (en) 1994-09-28
BG61595B1 (bg) 1998-01-30
SK280785B6 (sk) 2000-07-11
BG98825A (bg) 1995-05-31
UA41285C2 (uk) 2001-09-17
WO1993010792A1 (fr) 1993-06-10
CA2124793C (en) 2005-09-20
CZ134394A3 (en) 1994-12-15
ATE142499T1 (de) 1996-09-15
JPH07501534A (ja) 1995-02-16
AU3260093A (en) 1993-06-28
HUT68876A (en) 1995-08-28
SK68394A3 (en) 1995-03-08
JP3437574B2 (ja) 2003-08-18
GR3021876T3 (en) 1997-03-31
CZ284966B6 (cs) 1999-04-14
HU216826B (hu) 1999-09-28
LV11821B (en) 1997-12-20
FR2684381B1 (fr) 1995-05-05
DK0614366T3 (da) 1996-11-25
DE69213757T2 (de) 1997-04-03
CA2124793A1 (en) 1993-06-10
EP0614366A1 (fr) 1994-09-14
US5219846A (en) 1993-06-15
RO115784B1 (ro) 2000-06-30
ES2094522T3 (es) 1997-01-16
RU94030808A (ru) 1996-10-20
FR2684381A1 (fr) 1993-06-04
KR100235893B1 (ko) 1999-12-15
DE69213757D1 (de) 1996-10-17
RU2097040C1 (ru) 1997-11-27

Similar Documents

Publication Publication Date Title
ES2060310T3 (es) Utilizacion de la n-miristoil-(s)-fenilalanina para la obtencion de medicamentos destinados al tratamiento de enfermedades que hacen intervenir la miristoilacion.
MX9203370A (es) Desulfatohirudina y composiciones farmaceuticas que la contienen.
EA200100572A1 (ru) Способ применения ингибитора циклооксигеназы-2 и одного или нескольких противоопухолевых лекарственных средств в качестве комбинированного способа лечебного воздействия при лечении неоплазии
AU1876788A (en) Methylene phosphonoalkylphosphinates, pharmaceutical compositions , and methods for treating abnormal calcium and phosphate metabolism
LV11821A (lv) Savienojumu ar fosfonamida vai enola fosfata saiti pielietojums audzeju arstesanai
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
PT971922E (pt) Compostos de tetra-hidropirido
ATE107132T1 (de) Biozide zusammensetzungen und behandlungen.
DK0762883T3 (da) Pyridylbisphosphonater til anvendelse som terapeutisk middel
DK406589A (da) Middel til behandling af maligne tumorer, indeholdende 8-chloradenosin-3',5'-cyclisk phosphat, 8-aminoacenosin-3',5'-cyclisk phosphat
SE8602060L (sv) Farmaceutiska kompositioner som innehaller reducerad glutation
SE9802836D0 (sv) Läkemedel för behandling av schizofreni
ES1022431Y (es) Plantilla aromtica para calzado perfeccionada.
MX9203587A (es) Composicion farmaceutica para el tratamiento de la osteodistro fia renal.
ES261712Y (es) Disposicion para el tratamiento de calzados.
MX9709788A (es) Analogos de nucleotidos para tratamiento topico de enfermedades proliferativas de la piel.